These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10520525)

  • 21. The cost effectiveness of pneumococcal vaccination strategies.
    Gable CB; Botteman M; Savage G; Joy K
    Pharmacoeconomics; 1997 Aug; 12(2 Pt 1):161-74. PubMed ID: 10169668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pneumococcal vaccine.
    Stollerman GH
    JAMA; 1982 Apr; 247(13):1809-10. PubMed ID: 7062485
    [No Abstract]   [Full Text] [Related]  

  • 23. [The antipneumococcal vaccine--a second look].
    Sachs T
    Harefuah; 1981 Sep; 101(5-6):123-4. PubMed ID: 7344988
    [No Abstract]   [Full Text] [Related]  

  • 24. Pneumococcal vaccines and public health policy. Consequences of missed opportunities.
    Filice GA
    Arch Intern Med; 1990 Jul; 150(7):1373-5. PubMed ID: 2369235
    [No Abstract]   [Full Text] [Related]  

  • 25. Cost effectiveness of adding 7-valent pneumococcal conjugate (PCV-7) vaccine to the Norwegian childhood vaccination program.
    Wisløff T; Abrahamsen TG; Bergsaker MA; Løvoll Ø; Møller P; Pedersen MK; Kristiansen IS
    Vaccine; 2006 Jul; 24(29-30):5690-9. PubMed ID: 16735083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differences in attitudes, beliefs and knowledge of hospital health care workers and community doctors to vaccination of older people.
    Ridda I; Lindley IR; Gao Z; McIntyre P; Macintyre CR
    Vaccine; 2008 Oct; 26(44):5633-40. PubMed ID: 18706955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cost-effectiveness of universal pneumococcal vaccination for infants in Italy.
    Marchetti M; Colombo GL
    Vaccine; 2005 Aug; 23(37):4565-76. PubMed ID: 15992969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Anti-pneumococcal vaccination in elderly persons].
    Trivalle C
    Presse Med; 1998 Mar; 27(10):484-8. PubMed ID: 9767984
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug utilization.
    Pa Med; 1997 Nov; 100(11):36. PubMed ID: 9509878
    [No Abstract]   [Full Text] [Related]  

  • 30. Pneumococcal vaccine for Olympic athletes and visitors to Spain.
    Barnett ED; Klein JO; Teele DW
    N Engl J Med; 1992 Jun; 326(23):1572. PubMed ID: 1445525
    [No Abstract]   [Full Text] [Related]  

  • 31. [Antipneumococcal vaccine. Old controversies and new indications].
    Miravitlles M; de Gracia J
    Arch Bronconeumol; 1998 Jun; 34(6):295-9. PubMed ID: 9666288
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pneumococcal disease and emergence of serotypes in the vaccine era. Transient trends and serotype replacement?].
    Moraga-Llop FA
    Enferm Infecc Microbiol Clin; 2009 Jan; 27(1):1-4. PubMed ID: 19217995
    [No Abstract]   [Full Text] [Related]  

  • 33. [Antipneumococcal vaccine in older than 65 years of age].
    Castellote FJ; Atienza MP
    Aten Primaria; 1998 May; 21(9):646. PubMed ID: 9677752
    [No Abstract]   [Full Text] [Related]  

  • 34. Decreasing invasive pneumococcal disease in the elderly: a state-level analysis.
    McBean AM; Jung K; Hebert PL
    Vaccine; 2006 Jul; 24(27-28):5609-14. PubMed ID: 16725240
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacoeconomics of elderly vaccination against invasive pneumococcal infections: cost-effectiveness analyses and implications for The Netherlands.
    Postma MJ; Heijnen ML; Beutels P; Jager JC
    Expert Rev Vaccines; 2003 Aug; 2(4):477-82. PubMed ID: 14711333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotype distribution of Streptococcus pneumoniae in north-western Greece and implications for a vaccination programme.
    Levidiotou S; Vrioni G; Tzanakaki G; Pappa C; Gesouli H; Gartzonika C; Papamichail D; Kremastinou J
    FEMS Immunol Med Microbiol; 2006 Nov; 48(2):179-82. PubMed ID: 17064274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Childhood vaccination against pneumococcal otitis media and pneumonia: an analysis of benefits and costs.
    Weycker D; Richardson E; Oster G
    Am J Manag Care; 2000 Jul; 6(10 Suppl):S526-35. PubMed ID: 11183904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Antipneumococcal vaccine: up date and prospective].
    Caramia G; Pastorelli G
    Minerva Pediatr; 2005 Oct; 57(5):229-41. PubMed ID: 16205607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heptavalent Pneumococcal Conjugate Vaccine: growing knowledge and its implications for Italy.
    Durando P; Sticchi C; Compagnino F; Ansaldi F; Sticchi L; Gasparini R; Castiglia P; Lugarini J; Alberti M; Icardi G
    J Prev Med Hyg; 2008 Mar; 49(1):34-46. PubMed ID: 18792532
    [No Abstract]   [Full Text] [Related]  

  • 40. Lifesaving opportunities missed: the challenge of vaccinating older Americans for pneumococcal diseases and influenza.
    Tschantz K; Foley LA
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2000 Oct; (IB45):1-9. PubMed ID: 11885591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.